ISID Home
about ISID | membership | programs | publications | resources | 14th ICID | site map
 
ProMed Home
 
  Navigation
Home
Subscribe/Unsubscribe
Search Archives
Announcements
Recalls/Alerts
Calendar of Events
Maps of Outbreaks
Submit Info
FAQs
Who's Who
Awards
Citing ProMED-mail
Links
Donations
About ProMED-mail
 
Archive Number 20091006.3469
Published Date 06-OCT-2009
Subject PRO/AH> Ebola & Marburg hemorrhagic fever, Egyptian fruit bat - W. Africa

EBOLA AND MARBURG HEMORRHAGIC FEVER, EGYPTIAN FRUIT BAT - WEST AFRICA
*********************************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Fri 2 Oct 2009
Source: Bloomberg.com [edited]
<http://www.bloomberg.com/apps/news?pid=20601124&sid=aCDY59ymDHII>


Virus Hunters Find Ebola, Marburg Source in Fruit Bat
-----------------------------------------------------
Scientists are closing in on the source of Ebola and Marburg 
[hemorrhagic fevers], 2 of the world's most-lethal infectious 
diseases. After a 5-year search in the jungles of Africa, an 
international team of virus hunters has identified a fruit bat that 
may be the natural host for both hemorrhage-causing diseases. Also, 
these viruses are more widespread than previously thought, according 
to their research, which will be published via an open-access BioMed 
Central journal.

The study, based on blood tests on more than 2000 bats in Gabon and 
the Republic of Congo, will help scientists solve a mystery that has 
confounded them for more than 30 years: which species harbor Ebola 
and Marburg [viruses] without getting sick. The answer may explain 
how the viruses persist in the environment and point to ways humans 
can avoid a disease that causes fatal bleeding and organ failure in 
at least half of cases.

"Very eminent scientists have been searching for decades to find the 
source," said John Mackenzie, a Melbourne-based virologist who 
assists the World Health Organization in its response to outbreaks. 
"Until you know what it is, you can't piece together the epidemiology 
or begin to think about managing the risks to both humans and wildlife."

Marburg hemorrhagic fever was recognized in 1967, when outbreaks 
occurred in laboratories in Marburg and Frankfurt, Germany, and in 
the Serbian [Yugoslavian] capital, Belgrade. Cases were traced to 
African green monkeys imported for research and polio vaccine 
production. Then, 9 years later, a closely related virus was found to 
have sparked a deadly outbreak near the Ebola River in the Democratic 
Republic of Congo, formerly known as Zaire.

Disease trackers have tested everything from snakes to guinea pigs in 
the search for an animal reservoir and have been repeatedly led back 
to caves, mines and bats. A 2005 study published in the journal 
Nature found evidence of symptomless ebolavirus infection in 3 
species of fruit bat in West Africa, indicating that these animals 
may be the ones silently harboring the virus. In March [2009], 
scientists reported the 1st evidence directly connecting a human 
Ebola hemorrhagic fever outbreak to the putative fruit bat reservoir.

The study reported this week is the 1st to show that ebolavirus and 
marburgvirus are circulating simultaneously in bat populations in one 
country. While several human Ebola hemorrhagic fever outbreaks have 
occurred in Gabon, no cases of Marburg hemorrhagic fever have been 
reported there, the authors said. The presence of marburgvirus in the 
West African nation represents a "potential and previously 
unrecognized threat to humans," they said.

"These findings provide much stronger evidence for a reservoir in 
bats," Xavier Pourrut, a virologist at Gabon's International Center 
for Medical Research in Franceville and the study's lead author, said 
in a telephone interview. "The next step is to understand how the 
viruses circulate in bat populations over time." Pourrut and 
collaborators from the Special Pathogens Branch of the Centers for 
Disease Control and Prevention in Atlanta and France's Institute for 
Development Research looked for evidence of previous ebolavirus and 
marburgvirus infection in the blood samples of 2147 bats from at 
least 9 species. Tests were conducted from 2003 to 2008 in 3 regions 
of Gabon and in the Ebola epidemic region of north Congo.

Of all the bats sampled in significant numbers, only specimens of the 
cave-roosting Egyptian fruit bat, or _Rousettus aegyptiacus_, were 
found to harbor antibodies against both ebolavirus and marburgvirus, 
the authors wrote, "suggesting that this species may be a natural 
host of both viruses." The Egyptian rousette, with a doglike face and 
ears, is found along the Nile River in Egypt, across Sub-Saharan 
Africa, eastern Mediterranean and the Middle East. While some groups 
may occasionally roost outside in trees, the bats of this species 
prefer to inhabit caves, mines and tombs, and feast on fruit trees at 
night. These preferences give it a stronger link with the circulation 
of ebolavirus and marburgvirus more frequently found in rain forests, 
said Pierre Formenty, leader of the emerging and dangerous pathogens 
team at the World Health Organization (WHO) in Geneva.

Formenty was among 29 authors of a study published in July [2009] 
that showed Marburg virus could be isolated from seemingly healthy 
Egyptian fruit bats caught in Uganda's Kitaka Cave, where miners 
infected with the virus in 2007 had worked. While some outbreaks in 
humans have been directly linked to contact with bats, more evidence 
exists to link cases with infected apes, chimpanzees and other 
primates that are often consumed in Central Africa. These animals, in 
turn, probably got the virus by eating fruit contaminated with saliva 
or other bodily fluids from bats, according to Pourrut.

Once a human is infected, there is no cure for ebolavirus or 
marburgvirus infection. After an incubation period of about a week, 
victims rapidly develop high fever, diarrhea, vomiting, respiratory 
disorders and hemorrhaging. Death can ensue within a few days. About 
a quarter of Marburg hemorrhagic fever cases are fatal, whereas case 
fatality rates range from 50 to 80 percent with Ebola hemorrhagic 
fever in Africa.

Ebolavirus may circulate naturally within at least one other bat 
species and spread to members of the Egyptian rousette via contact 
with infected saliva left on fruit remnants, Formenty said in an 
interview. Also, no link with the Egyptian fruit bat was found with 
at least 3 Ebola hemorrhagic fever outbreaks, he said. "We've got a 
whole lot of clues on the crossword puzzle and we're just filling the 
blanks now," said Bob Swanepoel, a virologist at South Africa's 
National Institute for Communicable Diseases in Johannesburg, who 1st 
sought to unravel the history of Marburg hemorrhagic fever in the 
mid-1970s. Scientists will complete the task within a decade, he said.

[Byline: Jason Gale]

--
Communicated by:
ProMED-mail Rapporteur Mary Marshall.

[This report describes evidence linking for the 1st time both the 
Ebola and Marburg hemorrhagic fevers with viruses present in fruit 
bats, and one bat in particular -- the Egyptian fruit bat, _Rousettus 
aegyptiacus_. (An image of an Egyptian fruit bat can be viewed via 
the above URL for the news agency article.) The evidence for virus 
infection of these bats is based on serological analysis and it is 
unclear from this report whether infectious virus has been isolate 
from these animals. Publication of the data is awaited with interest. 
It is suggested that direct transmission of ebolavirus and 
marburgvirus to humans from these bats may be rare and that humans 
are more likely to be exposed to infection through contact with 
infected primates, hunted as a source of food.
- Mod.CP]

[The interactive HealthMap/ProMED map for Africa is available at:
<http://healthmap.org/r/0035>
- CopyEd.EJP]

[see also:
Ebola hemorrhagic fever, fruit bat - Congo DR, 2007  20090530.2014
2007
----
Marburgvirus, fruit bats - W. Africa  20070823.2755]
....................cp/ejp/dk

*##########################################################*
************************************************************
ProMED-mail makes every effort to  verify  the reports  that
are  posted,  but  the  accuracy  and  completeness  of  the
information,   and  of  any  statements  or  opinions  based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by  ProMED-mail.   ISID
and  its  associated  service  providers  shall not be  held
responsible for errors or omissions or  held liable for  any
damages incurred as a result of use or reliance upon  posted
or archived material.
************************************************************
Become     a    ProMED-mail    Premium     Subscriber     at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send  all  items  for   posting  to:   promed@promedmail.org

(NOT to  an  individual moderator).  If you do not give your
full name and  affiliation, it  may  not  be  posted.   Send
commands  to  subscribe/unsubscribe,   get  archives,  help,
etc. to: majordomo@promedmail.org.    For assistance  from a
human  being  send  mail  to:   owner-promed@promedmail.org.

############################################################
############################################################

about ISID | membership | programs | publications | resources
14th ICID | site map | ISID home

©2001,2009 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.